Buscar
Sanara Medtech Inc
SMTIAñadir a la lista de seguimiento
35.100USD
-0.050-0.14%
Cierre 09-24 16:00（ET）
322.57MCap. mercado
PérdidaP/E TTM
Acerca de Sanara Medtech Inc Compañía
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Perfil de Sanara Medtech Inc
Símbolo de cotizaciónSMTI
Nombre de la empresaSanara Medtech Inc
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMuppalla (Suresh V)
Número de empleados141
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 07
Dirección1200 Summit Avenue
CiudadFORT WORTH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal76102
Teléfono18175292300
Sitio Webhttps://sanaramedtech.com/
Símbolo de cotizaciónSMTI
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMuppalla (Suresh V)
Ejecutivos de Sanara Medtech Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.89K
-3.46%
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.89K
-3.46%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.89K
-3.46%
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.89K
-3.46%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sanara Medtech Inc?
Los cinco principales accionistas de Sanara Medtech Inc son: Mr. Seth D. Yon
¿Cuántas instituciones poseen acciones de Sanara Medtech Inc (SMTI)?
A fecha de 2026Q1, 131 instituciones poseen acciones de Sanara Medtech Inc, con un valor de mercado combinado de aproximadamente 1.42M, lo que representa el 15.50% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -599767.00.
¿Cuál es la mayor fuente de ganancias de Sanara Medtech Inc?
El 2026Q1, el segmento empresarial Soft tissue repair products generó la ganancia más alta para Sanara Medtech Inc, ascendiendo a 25.24M y representando el 89.71% de la ganancia total.